ConductScience.org, home

Trial · NCT07893600

Efficacy and Safety of OsrhCT Before Upper Endoscopy on Improving Visualization of the Gastric Mucosa.

NCT07893600, Phase 2, Not yet recruiting, Healthgen Biotechnology Corp.

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Efficacy and Safety of OsrhCT Before Upper Endoscopy on Improving Visualization of the Gastric Mucosa. Trials, record NCT07893600. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07893600

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Efficacy and Safety of OsrhCT Before Upper Endoscopy on Improving Visualization of the Gastric Mucosa.
NCT number
NCT07893600
Status
Not yet recruiting
Phases
Phase 2
Enrollment
40 participants, estimated
Lead sponsor
Healthgen Biotechnology Corp.
Conditions
Gastric Mucosal Lesion
Interventions
Recombinant Human Chymotrypsin(OsrhCT) 4000U, Placebo for Recombinant Human Chymotrypsin(OsrhCT)
First posted
2026-10-26
Last updated
2026-10-26

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTotal visibility score (TVS) evaluated by blinded endoscopistsThrough study completion, up to 2 months"Total visibility score"counted as the sum of visibility score in lower esophagus, gastric fundus, upper gastric body, lower gastric body and gastric antrum.
SecondaryVsibility scores evaluated by blinded endoscopists for mucosain of 5 various anatomical parts of the stomachThrough study completion, up to 2 monthsVsibility scores for the lower esophagus, antrum, lower gastric body, upper gastric body, and fundus.
SecondaryThe amount of water flushed for satisfactory observation of the upper gastrointestinal tractDuring diagnostic upper endoscopy, up to 1 hourAmount of water used to allow an suitable visualization of gastric mucosa
SecondaryDuration of endoscopyDuring diagnostic upper endoscopy, up to 1 hourTime to complete the upper endoscopy (from the time of oral intubation until complete removal of the endoscope)
SecondaryIncidence of adverse eventsup to 1 weekNumber of gastroscopy procedures with adverse event divided by the number of all gastroscopy procedures. Number of participants with treatment-related adverse events as assessed by CTCAE V6.0.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07893600

GET https://conductscience.org/api/trials/v1/NCT07893600/registered